Mariko Kano

910 total citations
23 papers, 731 citations indexed

About

Mariko Kano is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Mariko Kano has authored 23 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Ophthalmology, 15 papers in Radiology, Nuclear Medicine and Imaging and 1 paper in Molecular Biology. Recurrent topics in Mariko Kano's work include Retinal Diseases and Treatments (21 papers), Retinal Imaging and Analysis (10 papers) and Glaucoma and retinal disorders (10 papers). Mariko Kano is often cited by papers focused on Retinal Diseases and Treatments (21 papers), Retinal Imaging and Analysis (10 papers) and Glaucoma and retinal disorders (10 papers). Mariko Kano collaborates with scholars based in Japan and United States. Mariko Kano's co-authors include Masaaki Saito, Tomohiro Iida, Tetsuju Sekiryu, Ichiro Maruko, Hideki Koizumi, Annabelle A. Okada, Kanako Itagaki, Akiko Yamamoto, Akiko Yamamoto and Ayana Yamashita and has published in prestigious journals such as PLoS ONE, Ophthalmology and American Journal of Ophthalmology.

In The Last Decade

Mariko Kano

23 papers receiving 714 citations

Peers

Mariko Kano
Tae Gon Lee South Korea
Mee Yon Lee South Korea
Jung Il Han South Korea
Jacopo Guidotti United States
S.Y. Cohen France
Sharel Ongchin United States
Mariko Kano
Citations per year, relative to Mariko Kano Mariko Kano (= 1×) peers Seigo Yoneyama

Countries citing papers authored by Mariko Kano

Since Specialization
Citations

This map shows the geographic impact of Mariko Kano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariko Kano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariko Kano more than expected).

Fields of papers citing papers by Mariko Kano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariko Kano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariko Kano. The network helps show where Mariko Kano may publish in the future.

Co-authorship network of co-authors of Mariko Kano

This figure shows the co-authorship network connecting the top 25 collaborators of Mariko Kano. A scholar is included among the top collaborators of Mariko Kano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariko Kano. Mariko Kano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Saito, Masaaki, Tomohiro Iida, Kuniharu Saito, et al.. (2021). Long-term characteristics of exudative age-related macular degeneration in Japanese patients. PLoS ONE. 16(12). e0261320–e0261320. 6 indexed citations
3.
Saito, Masaaki, Mariko Kano, Kanako Itagaki, & Tetsuju Sekiryu. (2016). Efficacy of intravitreal aflibercept in Japanese patients with exudative age-related macular degeneration. Japanese Journal of Ophthalmology. 61(1). 74–83. 15 indexed citations
4.
Kano, Mariko, Tetsuju Sekiryu, Yukinori Sugano, et al.. (2015). Foveal structure during the induction phase of anti-vascular endothelial growth factor therapy for occult choroidal neovascularization in age-related macular degeneration. Clinical ophthalmology. 9. 2049–2049. 5 indexed citations
5.
Yamamoto, Akiko, Annabelle A. Okada, Mariko Kano, et al.. (2015). One-Year Results of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy. Ophthalmology. 122(9). 1866–1872. 108 indexed citations
6.
Koizumi, Hideki, Mariko Kano, Akiko Yamamoto, et al.. (2015). Aflibercept therapy for polypoidal choroidal vasculopathy: short-term results of a multicentre study. British Journal of Ophthalmology. 99(9). 1284–1288. 35 indexed citations
7.
Saito, Masaaki, et al.. (2015). Subfoveal choroidal thickness in polypoidal choroidal vasculopathy after switching to intravitreal aflibercept injection. Japanese Journal of Ophthalmology. 60(1). 35–41. 21 indexed citations
8.
Koizumi, Hideki, Mariko Kano, Akiko Yamamoto, et al.. (2015). Subfoveal Choroidal Thickness during Aflibercept Therapy for Neovascular Age-Related Macular Degeneration. Ophthalmology. 123(3). 617–624. 114 indexed citations
9.
Saito, Masaaki, et al.. (2014). SWITCHING TO INTRAVITREAL AFLIBERCEPT INJECTION FOR POLYPOIDAL CHOROIDAL VASCULOPATHY REFRACTORY TO RANIBIZUMAB. Retina. 34(11). 2192–2201. 41 indexed citations
10.
Koizumi, Hideki, Mariko Kano, Akiko Yamamoto, et al.. (2014). Short-Term Changes in Choroidal Thickness After Aflibercept Therapy for Neovascular Age-Related Macular Degeneration. American Journal of Ophthalmology. 159(4). 627–633.e1. 83 indexed citations
11.
Saito, Masaaki, Tomohiro Iida, Mariko Kano, & Kanako Itagaki. (2013). Two-year results of combined intravitreal ranibizumab and photodynamic therapy for polypoidal choroidal vasculopathy. Graefe s Archive for Clinical and Experimental Ophthalmology. 251(9). 2099–2110. 35 indexed citations
12.
Saito, Masaaki, Tomohiro Iida, Mariko Kano, & Kanako Itagaki. (2013). Five-year results of photodynamic therapy with and without supplementary antivascular endothelial growth factor treatment for polypoidal choroidal vasculopathy. Graefe s Archive for Clinical and Experimental Ophthalmology. 252(2). 227–235. 14 indexed citations
13.
Saito, Masaaki, Tomohiro Iida, K. Bailey Freund, Mariko Kano, & Lawrence A. Yannuzzi. (2013). Clinical Findings of Acquired Vitelliform Lesions Associated With Retinal Pigment Epithelial Detachments. American Journal of Ophthalmology. 157(2). 355–365.e2. 14 indexed citations
14.
Saito, Masaaki, Tomohiro Iida, & Mariko Kano. (2012). INTRAVITREAL RANIBIZUMAB FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION WITH GOOD BASELINE VISUAL ACUITY. Retina. 32(7). 1250–1259. 23 indexed citations
15.
Saito, Masaaki, Tomohiro Iida, & Mariko Kano. (2012). Two-year results of combined intravitreal anti-VEGF agents and photodynamic therapy for retinal angiomatous proliferation. Japanese Journal of Ophthalmology. 57(2). 211–220. 9 indexed citations
16.
Iida, Tomohiro, et al.. (2011). Near-Infrared Autofluorescence in Patients With Idiopathic Submacular Choroidal Neovascularization. American Journal of Ophthalmology. 153(2). 314–319. 17 indexed citations
17.
Saito, Masaaki, Tomohiro Iida, & Mariko Kano. (2011). INTRAVITREAL RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY WITH RECURRENT OR RESIDUAL EXUDATION. Retina. 31(8). 1589–1597. 29 indexed citations
18.
Saito, Masaaki, Tomohiro Iida, & Mariko Kano. (2011). Combined Intravitreal Ranibizumab and Photodynamic Therapy for Retinal Angiomatous Proliferation. American Journal of Ophthalmology. 153(3). 504–514.e1. 19 indexed citations
19.
Saito, Masaaki, Chieko Shiragami, Fumio Shiraga, Mariko Kano, & Tomohiro Iida. (2010). Comparison of Intravitreal Triamcinolone Acetonide With Photodynamic Therapy and Intravitreal Bevacizumab with Photodynamic Therapy for Retinal Angiomatous Proliferation. American Journal of Ophthalmology. 149(3). 472–481.e1. 24 indexed citations
20.
Ishigure, Takaaki, Mariko Kano, & Yasuhiro Koike. (1999). Propagating mode attenuation and coupling characteristics of graded-index POF. SaC2–SaC2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026